Immune Checkpoint Inhibitor-induced Pancreatitis with Pancreatic Enlargement Mimicking Autoimmune Pancreatitis: A Case Report and Review of the Literature-Reference-Cited by-同舟云学术

Immune Checkpoint Inhibitor-induced Pancreatitis with Pancreatic Enlargement Mimicking Autoimmune Pancreatitis: A Case Report and Review of the Literature

Published:2023 Issue: Volume: Page:
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Tanabe Kiyokuni¹,Yokoyama Kensuke¹,Kanno Atsushi¹,Ikeda Eriko¹,Ando Kozue¹,Nagai Hiroki¹,Koyanagi Takahiro²,Sakaguchi Mio³,Nakaya Takeo³,Tamada Kiichi¹,Niki Toshiro³,Fukushima Noriyoshi³,Lefor Alan Kawarai⁴,Yamamoto Hironori¹

Affiliation:

1. Department of Medicine, Division of Gastroenterology, Jichi Medical University, Japan

2. Department of Obstetrics & Gynecology, Jichi Medical University, Japan

3. Department of Diagnostic Pathology, Jichi Medical University, Japan

4. Department of Surgery, Jichi Medical University, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_1943-23/_pdf

Reference47 articles.

1. 1. Pennock GK, Chow LQ. The evolving role of immune checkpoint inhibitors in cancer treatment. Oncologist 20: 812-822, 2015.

2. 2. Darvin P, Toor SM, Sasidharan Nair V, Elkord E. Immune checkpoint inhibitors: recent progress and potential biomarkers. Exp Mol Med 50: 1-11, 2018.

3. 3. Postow MA, Sidlow R, Hellmann MD. Immune-related adverse events associated with immune checkpoint blockade. N Engl J Med 378: 158-168, 2018.

4. 4. Friedman CF, Clark V, Raikhel AV, et al. Thinking critically about classifying adverse events: incidence of pancreatitis in patients treated with nivolumab + ipilimumab. J Natl Cancer Inst 109: djw260, 2016.

5. 5. Su Q, Zhang XC, Zhang CG, Hou YL, Yao YX, Cao BW. Risk of immune-related pancreatitis in patients with solid tumors treated with immune checkpoint inhibitors: systematic assessment with meta-analysis. J Immunol Res 2018: 1027323, 2018.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pembrolizumab;Reactions Weekly;2024-04-13